Restaurant Meats Higher In Suspected Carcinogens

October 31, 1998

Fast food may be better for your health than steak from a restaurant, according to a just-released study by government scientists who found more cancer-causing compounds in restaurant-prepared meats than in fast food meats.

Suspected cancer-causing compounds known as heterocyclic amines, often formed during cooking, were found in restaurant-prepared meats at levels as much as ten times higher than similar fast food items previously analyzed by the scientists. The study involved beef hamburgers, steaks and pork ribs, purchased from three different national restaurant chains in the Beltsville, Md., area near Washington, D.C.

The study from Lawrence Livermore National Laboratory, the National Cancer Institute and the U.S. Department of Agriculture is reported in the Oct. 31 Web edition of the Journal of Agricultural and Food Chemistry, published by the American Chemical Society, the world's largest scientific society. It is scheduled to appear in the November 16 print edition of the peer-reviewed journal.

Heterocyclic amines are known carcinogens in animals and are believed to contribute to cancer in people.

"Time and temperature" probably account for the difference in fast food and that from other types of restaurants, says Livermore chemist Mark Knize, lead author for the report. Although fast food chains would not divulge their preparation secrets, he said, the researchers believe that fast food cooking times and temperatures are quicker and lower than other restaurants. Previous research has demonstrated that hotter temperatures and longer cooking times are important to the formation of heterocyclic amines.

This is the first time that measurements have been made of heterocyclic amines in meats specifically prepared by restaurant chefs, according to Knize. The "field test" is significant, he says, since it gives clear support to what previously had only been laboratory studies of the formation of the compounds. There are no established rules or guidelines for the acceptable level of heterocyclic amines in food, says Knize.
(The online version of the research paper cited below will be placed on the American Chemical Society's ASAP (As Soon As Publishable) web site on Oct. 31. Journalists desiring full access to papers at the ASAP site must submit their requests in writing to in the ACS Office of News & Information.)

American Chemical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to